Fulton Breakefield Broenniman Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$3.02M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$2.16M |
| 3 |
ExxonMobil
XOM
|
+$1.23M |
| 4 |
IBM
IBM
|
+$982K |
| 5 |
Merck
MRK
|
+$942K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$945K |
| 2 |
BCS.PRD.CL
Barclays Bank Plc
BCS.PRD.CL
|
+$274K |
| 3 |
BAC.PRJ
BANK OF AMERICA CORP Depositary sh repstg 1/1000th Pfd Ser J
BAC.PRJ
|
+$166K |
| 4 |
HP
HPQ
|
+$109K |
| 5 |
US Bancorp
USB
|
+$102K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.86% |
| 2 | Consumer Discretionary | 10.33% |
| 3 | Industrials | 10.31% |
| 4 | Consumer Staples | 9.68% |
| 5 | Energy | 8.54% |
Similar funds
Fulton Breakefield Broenniman's Q3 2013 Portfolio in Review
As of Q3 2013, Fulton Breakefield Broenniman held 139 positions worth $371M, up 8.8% from $341M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Fulton Breakefield Broenniman deployed $21.8M of net new capital in Q3 2013, opening 7 new positions and adding to 102 existing holdings. Its largest new stake was Merck: 20,633 shares worth $937K.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was HP, an estimated $109K trimmed.
- Fulton Breakefield Broenniman's largest Q3 2013 buy was Merck: 20,633 shares worth $937K.
- Fulton Breakefield Broenniman added most to Union Pacific in Q3 2013, an estimated $3.02M increase.
- Fulton Breakefield Broenniman's biggest Q3 2013 reduction was HP, cutting an estimated $109K.
- Fulton Breakefield Broenniman fully exited BROADCOM CORP CL-A in Q3 2013, selling an estimated $945K.
- Fulton Breakefield Broenniman's ten largest holdings make up 19% of its $371M portfolio in Q3 2013.
- Fulton Breakefield Broenniman opened 7 new positions and closed 3 in Q3 2013.
- Fulton Breakefield Broenniman's portfolio value rose 8.8% quarter-over-quarter to $371M.
Based on Fulton Breakefield Broenniman's 13F filing for Q3 2013, filed 22 Oct 2013.